|PhotoCure ASA -- Norway Stock|| |
NOK 27.1 0.05 0.18%
Head of Nordic Cancer Commercial Operations
Mr. Espen Njastein was Head of Nordic Cancer Commercial Operations at Photocure ASA since January 2012. He was previously Nordic Cancer Commercial Operations Director at the Company since July 2010. He joined the Company in 2007 as Nordic Sales Manager. He has a degree in marketing from The Norwegian School of Marketing. Before joining Photocure, Espen Njastein has held different positions within sales and marketing at Pfizer. He came from a position as Training and Development Manager in Pfizer.
Executive Since 2012
47 22 06 22 10 http://www.photocure.com
The company has return on total asset (ROA)
of (8.33) %
which means that it has lost $8.33 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (1.65) %
meaning that it generated substantial loss on money invested by shareholders.
Photocure ASA engages in the research, development, production, distribution, marketing, and sale of pharmaceutical solutions and related technical medical equipment. PhotoCure ASA (PHO) is traded on Oslo Stock Exchange in Norway. It is located in Oslo, and employs 49 people.